Fusafungine: Difference between revisions
m (Protected "Fusafungine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +)) |
||
| Line 28: | Line 28: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 39: | Line 39: | ||
[[Category:Antimicrobial peptides]] | [[Category:Antimicrobial peptides]] | ||
[[fr:Fusafungine]] | [[fr:Fusafungine]] | ||
[[hu:Fusafungin]] | [[hu:Fusafungin]] | ||
Revision as of 02:55, 9 August 2012
| Clinical data | |
|---|---|
| Synonyms | Fusafungin |
| ATC code | |
| Identifiers | |
| CAS Number | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C29H51N2O8 |
| Molar mass | 555.73 g·mol−1 |
|
WikiDoc Resources for Fusafungine |
|
Articles |
|---|
|
Most recent articles on Fusafungine Most cited articles on Fusafungine |
|
Media |
|
Powerpoint slides on Fusafungine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fusafungine at Clinical Trials.gov Clinical Trials on Fusafungine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fusafungine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Fusafungine Discussion groups on Fusafungine Patient Handouts on Fusafungine Directions to Hospitals Treating Fusafungine Risk calculators and risk factors for Fusafungine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fusafungine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fusafungine (INN), also known as fusafungin, is an active agent used in antibiotics for treatment of nasal and throat infection. It also possesses anti-inflammatory properties. It is produced by the ascomycete Fusarium lateririum, and marketed by Servier under the trade name Locabiotal and Bioparox - in Austria, Germany and Switzerland under the tade name Locabiosol.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antibiotics
- Antimicrobial peptides